by fiquiong | Nov 30, 2025 | News
Cenares acquires high-cost medication, known as triple immunomodulatory therapy (Elecaftor – Ivacaftor-Tezacaftor) The Peruvian Ministry of Health, through the National Center for the Supply of Strategic Health Resources (Cenares), has achieved a historic milestone in...
by fiquiong | Nov 30, 2025 | News
Starting today, the Government, through the Ministry of Health (Minsa) , will deliver for the first time high-cost medications to improve the quality of life of patients with cystic fibrosis, an orphan and rare disease that had limited coverage in the...
by fiquiong | Nov 30, 2025 | News
ALYFTREK modulator approved in the United States, United Kingdom, European Union and Canada
by fiquiong | Nov 30, 2025 | News
Law N.° 29698 Law declaring the treatment of people suffering from rare or orphan diseases to be of National Interest and a priority. This regulation belongs to the compendium of Regulations on Rare and Orphan Diseases Read More...
by fiquiong | Nov 30, 2025 | News
LAW THAT MODIFIES LAW 29698, LAW DECLARING OF NATIONAL INTEREST And priority attention to the treatment of people suffering from rare or orphan diseases Article 1.- Amendment of articles 3, 4, 5, 6 and 7 of Law 29698, Law that declares the treatment of people...
